Literature DB >> 20074811

The structure and dimensionality of the Inventory of Depressive Symptomatology Self Report (IDS-SR) in patients with depressive disorders and healthy controls.

Klaas J Wardenaar1, Tineke van Veen, Erik J Giltay, Margien den Hollander-Gijsman, Brenda W J H Penninx, Frans G Zitman.   

Abstract

BACKGROUND: The Inventory of Depressive Symptomatology Self Report (IDS-SR) is a widely used but heterogeneous measure of depression severity. Insight in its factor structure and dimensionality could help to develop more homogeneous IDS-SR subscales. However previous factoranalytical studies have found mixed results. Therefore, the present study tested which factor structure underlies the IDS-SR and, in addition, if the factors can be used as unidimensional subscales.
METHODS: Confirmatory factor analysis (CFA) was done to identify the best-fitting factor structure. The study sample consisted of 2600 individuals (mean age 40.5+/-12.1). We assessed model fit in 4 groups: 957 Major Depressive Disorder (MDD) patients, 450 remitted MDD patients, 570 patients with an anxiety disorder and 623 healthy controls to test the consistency of model fit. Rasch analyses in the full sample were used to evaluate and optimize the unidimensionality and psychometric quality of the factors.
RESULTS: CFA indicated that a 3-factor model fits the IDS-SR data best and is consistent across groups, with a 'mood/cognition' factor, an 'anxiety/arousal' factor and a 'sleep' factor. In addition, Rasch analyses indicated that the 'mood/cognition' and 'anxiety/arousal' factors could be optimized to be used as unidimensional subscales. LIMITATIONS: The fit of only 4 models was tested, ranging from a 1- to 4-factor model.
CONCLUSIONS: The IDS-SR is a heterogeneous instrument with a multifactorial underlying structure. It is possible to measure more homogeneous symptomatology with IDS-SR subscales, which could be useful in clinical practice and scientific research. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20074811     DOI: 10.1016/j.jad.2009.12.020

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  15 in total

1.  Longitudinal evaluation of anhedonia as a mediator of fear of positive evaluation and other depressive symptoms.

Authors:  D Gage Jordan; E Samuel Winer; Taban Salem; Jenna Kilgore
Journal:  Cogn Emot       Date:  2017-03-06

2.  Correlates of (inappropriate) benzodiazepine use: the Netherlands Study of Depression and Anxiety (NESDA).

Authors:  Leonie Manthey; Tineke van Veen; Erik J Giltay; José E Stoop; Arie Knuistingh Neven; Brenda W J H Penninx; Frans G Zitman
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

3.  High dose benzodiazepines prolong reaction times in chronic users who have major depressive and/or anxiety disorders.

Authors:  Leonie Manthey; Fawzia van Loenen-Frösch; Erik J Giltay; Tineke van Veen; Klaske Glashouwer; Brenda W J H Penninx; Frans G Zitman
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

4.  Psychometric properties of the IDS-SR30 for the assessment of depressive symptoms in Spanish population.

Authors:  Margalida Gili; Juan V Luciano; Natalia Bauzá; Jaume Aguado; María J Serrano; Silvia Armengol; Miquel Roca
Journal:  BMC Med Res Methodol       Date:  2011-09-21       Impact factor: 4.615

5.  Simultaneous Decomposition of Depression Heterogeneity on the Person-, Symptom- and Time-Level: The Use of Three-Mode Principal Component Analysis.

Authors:  Rei Monden; Klaas J Wardenaar; Alwin Stegeman; Henk Jan Conradi; Peter de Jonge
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

6.  The associations of depression and hypertension with brain volumes: Independent or interactive?

Authors:  Maaike Meurs; Nynke A Groenewold; Annelieke M Roest; Nic J A van der Wee; Dick J Veltman; Marie-José van Tol; Peter de Jonge
Journal:  Neuroimage Clin       Date:  2015-03-28       Impact factor: 4.881

7.  Decomposing the heterogeneity of depression at the person-, symptom-, and time-level: latent variable models versus multimode principal component analysis.

Authors:  Stijn de Vos; Klaas J Wardenaar; Elisabeth H Bos; Ernst C Wit; Peter de Jonge
Journal:  BMC Med Res Methodol       Date:  2015-10-15       Impact factor: 4.615

8.  The Inventory of Depressive Symptomatology Self Report (IDS-SR): Psychometric properties of the Indonesian version.

Authors:  Retha Arjadi; Maaike H Nauta; Dharmayati B Utoyo; Claudi L H Bockting
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

9.  Contributing factors to advanced brain aging in depression and anxiety disorders.

Authors:  Laura K M Han; Hugo G Schnack; Rachel M Brouwer; Dick J Veltman; Nic J A van der Wee; Marie-José van Tol; Moji Aghajani; Brenda W J H Penninx
Journal:  Transl Psychiatry       Date:  2021-07-21       Impact factor: 6.222

10.  The role of anxious distress in immune dysregulation in patients with major depressive disorder.

Authors:  Roxanne Gaspersz; Femke Lamers; Gayle Wittenberg; Aartjan T F Beekman; Albert M van Hemert; Robert A Schoevers; Brenda W J H Penninx
Journal:  Transl Psychiatry       Date:  2017-12-08       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.